Philippines - English - FDA (Food And Drug Administration)

phil pharmawealth inc - clonidine hydrochloride - tablet - 150mcg

Philippines - English - FDA (Food And Drug Administration)

phil pharmawealth inc - promethazine (as hydrochloride) - solution for injection im/iv - 25mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - conjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus; conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1) - powder and solvent for solution for injection - 0.5 millilitre(s) - hemophilus influenzae b, combinations with meningococcus c, conjugated

Malta - English - Medicines Authority

om pharma s.a. r. da industria, 2, 2610-088 amadora, lisboa, portugal - lyophilized bacterial, lysates - capsule - lyophilized bacterial lysates 7 mg - other respiratory system products

Malta - English - Medicines Authority

om pharma s.a. r. da industria, 2, 2610-088 amadora, lisboa, portugal - lyophilized bacterial, lysates - capsule - lyophilized bacterial lysates 3.5 mg - other respiratory system products

Malta - English - Medicines Authority

bruschettini s.r.l. via isonzo 6 - 16147 genova, italy - lyophilized bacterial, lysates - tablet - lyophilized bacterial lysates 50 mg - vaccines

Philippines - English - FDA (Food And Drug Administration)

philippines; importer: n/a; distributor: merck sharp & dohme (i.a.) llc - measles, mumps rubella and varicella vaccine (live) - lyophilized powder for solution for injection (sc) - each dose (0.5 ml) contains: measles virus (edmonston b) 3.00 log tcid50* mumps virus (jeryl lynn b level)4.30 log tcid50 rubella virus (wistar ra 27/3) 3.00 log tcid50 varicella virus (oka/merck) 3.99 pfu** *50% tissue culture infectious dose **plaque forming units

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: getz pharma (phils.), inc.; distributor: n/a - omeprazole (as sodium) - lyophilized powder for intravenous injection and infusion - 40mg/vial

European Union - English - EMA (European Medicines Agency)

sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib).the use of this vaccine should be in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

sanofi pasteur msd, snc - purified diphtheria toxoid, purified tetanus toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis b surface antigen, inactivated type 1 poliovirus (mahoney), inactivated type 2 poliovirus (mef 1), inactivated type 3 poliovirus (saukett), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - this combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis b caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by haemophilus influenzae type b.